Roxana Mehran, MD, a renowned cardiologist and professor of medicine at Columbia University, has assumed the presidency of the American College of Cardiology (ACC), effective March 25, 2024. Her inauguration marks a significant moment for the 58,000-member professional organization, as she takes the helm at a time of rapid innovation and evolving challenges in cardiovascular care. The ACC presidency is a year-long term, and Mehran’s leadership is expected to focus on advancing health equity, promoting cutting-edge research, and advocating for policies that improve heart health for all.
Mehran’s career has been dedicated to improving outcomes for patients with heart disease, particularly those undergoing percutaneous coronary intervention (PCI)—a minimally invasive procedure to open blocked arteries. She is internationally recognized for her work in understanding and mitigating the risks of bleeding and clotting associated with these procedures, and has been instrumental in developing guidelines that have become standard practice worldwide. Her expertise in interventional cardiology and commitment to patient-centered care position her as a strong advocate for the ACC’s mission.
A Career Focused on Innovation and Equity
Dr. Mehran currently serves as the Louis L. Kavoussi Professor of Cardiology at Columbia University Vagelos College of Physicians and Surgeons and Director of the Center for Interventional Cardiovascular Research and Trials at NewYork-Presbyterian/Columbia University Irving Medical Center. She previously held a prominent position at Mount Sinai Hospital in New York City, where she was a professor of medicine and director of interventional cardiology. Mount Sinai announced her appointment to the ACC presidency in March 2024, highlighting her decades of contributions to the field.
Mehran’s research has consistently broken new ground. She has led numerous landmark clinical trials that have shaped the way doctors treat patients with heart disease. Her work extends beyond the technical aspects of cardiology; she is a vocal advocate for addressing systemic inequities in healthcare access and outcomes. She has consistently championed the need for greater diversity in clinical trials and for tailoring treatment strategies to the unique needs of different patient populations. This commitment to health equity is expected to be a central theme of her presidency.
Priorities for the American College of Cardiology
In her inaugural address at ACC.26, the organization’s annual scientific conference held in Atlanta, Mehran outlined her vision for the year ahead. The American College of Cardiology published her address, which emphasized the importance of embracing innovation while remaining grounded in the principles of evidence-based medicine. She specifically called for increased investment in research focused on precision medicine, artificial intelligence, and digital health technologies.
Mehran also stressed the need for the ACC to play a more active role in advocating for policies that support cardiovascular health. This includes advocating for increased funding for research, expanding access to affordable healthcare, and addressing social determinants of health that contribute to heart disease. She acknowledged the challenges posed by rising healthcare costs and the need for innovative solutions to ensure that all patients have access to the care they need.
Addressing the Challenges of Cardiovascular Disease
Cardiovascular disease remains the leading cause of death worldwide, according to the World Health Organization. In the United States, heart disease accounts for one in five deaths. The burden of cardiovascular disease is particularly high among underserved populations, who often face barriers to accessing quality care. Mehran’s presidency comes at a critical time, as the ACC seeks to address these challenges and improve heart health for all Americans.
One of the key areas of focus for Mehran will be promoting the adoption of new technologies and treatment strategies. Advances in imaging, genomics, and data analytics are transforming the field of cardiology, offering the potential for more personalized and effective care. However, ensuring that these advances are accessible to all patients will require a concerted effort to address disparities in healthcare access and affordability.
Mehran’s leadership is also expected to focus on strengthening the ACC’s role as a global leader in cardiovascular education and training. The ACC offers a wide range of educational programs for cardiologists and other healthcare professionals, and Mehran is committed to expanding these programs to reach a wider audience. She believes that investing in the education of the next generation of cardiologists is essential to ensuring the future of cardiovascular care.
Looking ahead, the ACC under Mehran’s leadership will continue to prioritize research, advocacy, and education. The organization will also focus on fostering collaboration among healthcare professionals, researchers, and policymakers to address the complex challenges facing the field of cardiology. The next major event on the ACC calendar is ACC.27, scheduled for April 2025 in Orlando, Florida, where further initiatives and progress will be unveiled.
Disclaimer: The information provided in this article is for general knowledge and informational purposes only, and does not constitute medical advice. It’s essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
What are your thoughts on Dr. Mehran’s vision for the future of cardiology? Share your comments below, and please share this article with your network.
